1. Home
  2. BGX vs ADAG Comparison

BGX vs ADAG Comparison

Compare BGX & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Long Short Credit Income Fund

BGX

Blackstone Long Short Credit Income Fund

HOLD

Current Price

$10.54

Market Cap

139.7M

Sector

Finance

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

N/A

Current Price

$3.09

Market Cap

146.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGX
ADAG
Founded
N/A
2011
Country
United States
China
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.7M
146.3M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
BGX
ADAG
Price
$10.54
$3.09
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.00
AVG Volume (30 Days)
127.9K
74.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3,688.61
Revenue Next Year
N/A
$17.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.68
$1.33
52 Week High
$12.65
$3.53

Technical Indicators

Market Signals
Indicator
BGX
ADAG
Relative Strength Index (RSI) 12.80 57.41
Support Level N/A $1.64
Resistance Level $11.89 $3.19
Average True Range (ATR) 0.11 0.25
MACD -0.03 -0.06
Stochastic Oscillator 0.00 41.33

Price Performance

Historical Comparison
BGX
ADAG

About BGX Blackstone Long Short Credit Income Fund

Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It seeks to achieve its investment objectives by employing a dynamic long-short strategies in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: